ZBIO (Zenas BioPharma) FCF Margin % : -772.56% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Zenas BioPharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Zenas BioPharma's Free Cash Flow for the three months ended in Dec. 2024 was $-38.63 Mil. Zenas BioPharma's Revenue for the three months ended in Dec. 2024 was $5.00 Mil. Therefore, Zenas BioPharma's FCF Margin % for the quarter that ended in Dec. 2024 was -772.56%.

As of today, Zenas BioPharma's current FCF Yield % is -37.18%.

The historical rank and industry rank for Zenas BioPharma's FCF Margin % or its related term are showing as below:

ZBIO' s FCF Margin % Range Over the Past 10 Years
Min: -2396.1 Med: -1228.6 Max: -61.09
Current: -2396.1

During the past 3 years, the highest FCF Margin % of Zenas BioPharma was -61.09%. The lowest was -2396.10%. And the median was -1228.60%.

ZBIO's FCF Margin % is ranked worse than
84.62% of 1008 companies
in the Biotechnology industry
Industry Median: -129.705 vs ZBIO: -2396.10

Zenas BioPharma FCF Margin % Historical Data

The historical data trend for Zenas BioPharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenas BioPharma FCF Margin % Chart

Zenas BioPharma Annual Data

Trend

Dec22

Dec23

Dec24

FCF Margin %

-61.09

-2,396.10

Zenas BioPharma Quarterly Data
	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial					-	-	-	-	-772.56

Competitive Comparison of Zenas BioPharma's FCF Margin %

For the Biotechnology subindustry, Zenas BioPharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zenas BioPharma's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zenas BioPharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Zenas BioPharma's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Zenas BioPharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Zenas BioPharma's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-119.805	/	5
	=	-2,396.10 %

Zenas BioPharma's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-38.628	/	5
	=	-772.56 %

Zenas BioPharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of Zenas BioPharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zenas BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenas BioPharma Inc (NAS:ZBIO) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

852 Winter Street, Suite 250, Waltham, MA, USA, 02451

Website

https://www.zenasbio.com

Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.